Regulation of CD28 binding to SH2 domains of Grb2 and PI3K by trisubstituted carboranes for T-cell activation.

Binding of adaptor molecules, such as growth factor receptor-bound protein 2 (Grb2) and phosphoinositide 3-kinase (PI3K), to the cytoplasmic region of CD28 is critical for T-cell activation. The Src homology 2 (SH2) domains of Grb2 and PI3K interact with the cytoplasmic region, including phosphorylated Tyr, of CD28. We found that trisubstituted carboranes efficiently increased the proliferation of T cells obtained from C57BL/6 mice. The carboranes specifically increased the binding of Grb2 Src homology 2 (SH2) to CD28-derived phosphopeptide but decreased the binding of PI3K C-terminal SH2 (cSH2). Based on the crystal structures of CD28-derived phosphopeptides complexed with Grb2 SH2 and PI3K cSH2, the bound structures of compound 4 (CRL266481) were modeled to determine the molecular mechanism of the regulation.

Interdomain interactions in Grb2 revealed by the conformational stability and CD28 binding analysis.

Growth-factor receptor-bound protein 2 (Grb2) is an adaptor protein involved in signal transduction. The protein contains a central SH2 domain with N-terminal and C-terminal SH3 domains. We analyzed the SH3 involvement in Grb2 binding to the cytoplasmic region of CD28 receptor, using Grb2 and its SH3-deletion mutants, Grb2_nSH3del and Grb2_cSH3del, as the monomer state. The CD28 binding affinity of Grb2_nSH3del determined from surface plasmon resonance experiments was similar to that of Grb2_cSH3del, which was lower than that of Grb2 and higher than that of Grb2 SH2. The findings indicated that one of the SH3 domains is involved in CD28 binding. We also analyzed the thermal stabilities of Grb2 and its SH3-deletion mutants using differential scanning calorimetry, showing that the order of stability was Grb2_nSH3del < Grb2 < Grb2_cSH3del. Folding thermodynamics results indicated that SH3 domains, particularly nSH3, contribute to stabilizing the structure of Grb2, possibly due to the interdomain interaction.

Molecular interactions of the CTLA-4 cytoplasmic region with the phosphoinositide 3-kinase SH2 domains.

During T-cell regulation, T-cell receptors and CD28 lead to signaling activation, while T-lymphocyte antigen 4 (CTLA-4) is known to lead to downregulation, similar to programmed cell death-1 (PD-1). In the cytoplasmic tails of CD28 and CTLA-4, phosphoinositide 3-kinase (PI3K) binds to the consensus sequence including phosphotyrosine via SH2 domains, N- and C-terminal SH2 domains (nSH2 and cSH2), of its regulatory subunit, p85. In this study, we determined the crystal structure of a CTLA-4-derived phosphopeptide in complex with a Cys-substituted mutant of cSH2, C656S/C659V/C670L, at a 1.1 Å resolution. Phosphotyrosine of the bound peptide is tightly accommodated by the residues Arg631, Arg649, Ser651, and Ser652, similar to the cSH2 wild-type recognition mode of CD28, as reported previously. Upon the Cys mutation, the cSH2 thermal stability increased while the CTLA-4 binding affinity slightly changed. The binding experiments also showed that the binding affinity of CTLA-4 by cSH2 was approximately two orders of magnitude lower than that of CD28. Similar to CD28 binding, the CTLA-4 binding affinity of nSH2 was lower than that of cSH2. The complex structure of nSH2 and CTLA-4 was modeled, and compared with the crystal structure of cSH2 mutant and CTLA-4. The difference in the binding affinity between CD28 and CTLA-4, along with the difference between nSH2 and cSH2, could be explained by the 3D structures, which would be closely correlated with the respective T-cell signaling.